1. S1B(R1) addendum to S1B testing for carcinogenicity of pharmaceuticals: guidance for industry Publication: Silver Spring, MD : Center for Drug Evaluation and Research, November 2022 Subject(s): Carcinogenicity Tests -- standardsDrug Evaluation, PreclinicalGovernment RegulationUnited StatesUnited States. Food and Drug Administration
